282 related articles for article (PubMed ID: 10651385)
1. Platelet glycoprotein IIb/IIIa receptor antagonists: current concepts and future directions.
Ferguson JJ; Zaqqa M
Drugs; 1999 Dec; 58(6):965-82. PubMed ID: 10651385
[TBL] [Abstract][Full Text] [Related]
2. Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease.
Berkowitz SD
Haemostasis; 2000; 30 Suppl 3():27-43. PubMed ID: 11182626
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
Konstantopoulos K; Mousa SA
Curr Opin Investig Drugs; 2001 Aug; 2(8):1086-92. PubMed ID: 11892918
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein IIb/IIIa antagonists--from bench to practice.
Casserly IP; Topol EJ
Cell Mol Life Sci; 2002 Mar; 59(3):478-500. PubMed ID: 11964126
[TBL] [Abstract][Full Text] [Related]
5. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
[TBL] [Abstract][Full Text] [Related]
6. Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.
De Luca G; Savonitto S; van't Hof AW; Suryapranata H
Drugs; 2015 Jul; 75(11):1229-53. PubMed ID: 26177890
[TBL] [Abstract][Full Text] [Related]
7. Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker.
Liu F; Craft RM; Morris SA; Carroll RC
Expert Opin Investig Drugs; 2000 Nov; 9(11):2673-87. PubMed ID: 11060829
[TBL] [Abstract][Full Text] [Related]
8. Platelet glycoprotein IIb/IIIa receptor antagonists.
Casserly IP; Moliterno DJ
Expert Opin Pharmacother; 2000 Mar; 1(3):419-33. PubMed ID: 11249527
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of GP IIb/IIIa receptor antagonists in acute myocardial infarction.
Ferguson JJ; Vaisman D
Expert Opin Investig Drugs; 2001 Nov; 10(11):1965-76. PubMed ID: 11772300
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of glycoprotein IIb-IIIa inhibitors.
Kleiman NS
Am Heart J; 1999 Oct; 138(4 Pt 2):263-75. PubMed ID: 10502232
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy.
Lippi G; Montagnana M; Danese E; Favaloro EJ; Franchini M
Biomark Med; 2011 Feb; 5(1):63-70. PubMed ID: 21319966
[TBL] [Abstract][Full Text] [Related]
12. Anti-platelet therapy: glycoprotein IIb-IIIa antagonists.
Schneider DJ
Br J Clin Pharmacol; 2011 Oct; 72(4):672-82. PubMed ID: 21906121
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents.
Schafer AI
Tex Heart Inst J; 1997; 24(2):90-6. PubMed ID: 9205981
[TBL] [Abstract][Full Text] [Related]
14. [The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].
Galli M; Maggioni AP; Vassanelli C; Tavazzi L
Ital Heart J Suppl; 2000 Feb; 1(2):202-11. PubMed ID: 10731377
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet intervention in acute coronary syndrome.
Arora RR; Rai F
Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro.
Hamilton SF; Miller MW; Thompson CA; Dale GL
J Lab Clin Med; 2004 May; 143(5):320-6. PubMed ID: 15122176
[TBL] [Abstract][Full Text] [Related]
17. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
Adgey AA
Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518
[TBL] [Abstract][Full Text] [Related]
18. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.
Harrington RA
Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A.
Ching S; Thoma A; Monkman S; Kelton JG
Plast Reconstr Surg; 2003 Jul; 112(1):177-85. PubMed ID: 12832891
[TBL] [Abstract][Full Text] [Related]
20. Effects of GP IIb/IIIa inhibitors on vascular inflammation, coronary microcirculation, and platelet function.
Kereiakes DJ
Rev Cardiovasc Med; 2006; 7 Suppl 4():S3-11. PubMed ID: 17224889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
